Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05875987 · ClinicalTrials.gov registry record
Evaluation of the Quantra QStat System in Obstetric Patients
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 50
- Enrollment target
NCT05875987 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 50 participants.
The verdict
NCT05875987 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
Interventions
- DEVICE Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2024-05-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05875987
The ClinicalTrials.gov registry entry for NCT05875987 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT05875987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05875987 about?
NCT05875987 is a clinical study titled "Evaluation of the Quantra QStat System in Obstetric Patients". This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
What is the current status of trial NCT05875987?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2023-06-01. Estimated completion is 2024-05-10.
What interventions are being tested in trial NCT05875987?
The interventions under investigation include: Quantra System (DEVICE).
Who is sponsoring clinical trial NCT05875987?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.